0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IL-4Rα Monoclonal Antibody Drug Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-5M17634
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global IL 4Rα Monoclonal Antibody Drug Market Research Report 2024
BUY CHAPTERS

Global IL-4Rα Monoclonal Antibody Drug Market Research Report 2024

Code: QYRE-Auto-5M17634
Report
July 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

IL-4Rα Monoclonal Antibody Drug Market

Interleukin-4 (IL-4) is a glycosylated type I cytokine with a molecular size of approximately 20 kD, three intrachain disulfide bonds, and a bundled four-alpha helical structure. It is mainly produced by activated T cells, mast cells, eosinophils, and basophils. IL-4 has immunoregulatory effects on B cells, T cells, mast cells, macrophages, and hematopoietic cells, and is very important for the development of T and B lymphocytes and for driving humoral immune responses and antibody production.
The global IL-4Rα Monoclonal Antibody Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for IL-4Rα Monoclonal Antibody Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for IL-4Rα Monoclonal Antibody Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of IL-4Rα Monoclonal Antibody Drug include Regeneron, Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for IL-4Rα Monoclonal Antibody Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IL-4Rα Monoclonal Antibody Drug.
The IL-4Rα Monoclonal Antibody Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global IL-4Rα Monoclonal Antibody Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IL-4Rα Monoclonal Antibody Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of IL-4Rα Monoclonal Antibody Drug Market Report

Report Metric Details
Report Name IL-4Rα Monoclonal Antibody Drug Market
Segment by Type
  • 200mg (1.14mL)/Vial
  • 300mg (2.0 mL)/Vial
Segment by Application
  • Atopic Dermatitis
  • Asthma
  • Chronic Sinusitis with Nasal Polyps
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Regeneron, Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of IL-4Rα Monoclonal Antibody Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of IL-4Rα Monoclonal Antibody Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the IL-4Rα Monoclonal Antibody Drug Market report?

Ans: The main players in the IL-4Rα Monoclonal Antibody Drug Market are Regeneron, Sanofi

What are the Application segmentation covered in the IL-4Rα Monoclonal Antibody Drug Market report?

Ans: The Applications covered in the IL-4Rα Monoclonal Antibody Drug Market report are Atopic Dermatitis, Asthma, Chronic Sinusitis with Nasal Polyps, Other

What are the Type segmentation covered in the IL-4Rα Monoclonal Antibody Drug Market report?

Ans: The Types covered in the IL-4Rα Monoclonal Antibody Drug Market report are 200mg (1.14mL)/Vial, 300mg (2.0 mL)/Vial

1 IL-4Rα Monoclonal Antibody Drug Market Overview
1.1 Product Definition
1.2 IL-4Rα Monoclonal Antibody Drug by Type
1.2.1 Global IL-4Rα Monoclonal Antibody Drug Market Value Comparison by Type (2024-2030)
1.2.2 200mg (1.14mL)/Vial
1.2.3 300mg (2.0 mL)/Vial
1.3 IL-4Rα Monoclonal Antibody Drug by Application
1.3.1 Global IL-4Rα Monoclonal Antibody Drug Market Value by Application (2024-2030)
1.3.2 Atopic Dermatitis
1.3.3 Asthma
1.3.4 Chronic Sinusitis with Nasal Polyps
1.3.5 Other
1.4 Global IL-4Rα Monoclonal Antibody Drug Market Size Estimates and Forecasts
1.4.1 Global IL-4Rα Monoclonal Antibody Drug Revenue 2019-2030
1.4.2 Global IL-4Rα Monoclonal Antibody Drug Sales 2019-2030
1.4.3 Global IL-4Rα Monoclonal Antibody Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 IL-4Rα Monoclonal Antibody Drug Market Competition by Manufacturers
2.1 Global IL-4Rα Monoclonal Antibody Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global IL-4Rα Monoclonal Antibody Drug Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of IL-4Rα Monoclonal Antibody Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IL-4Rα Monoclonal Antibody Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IL-4Rα Monoclonal Antibody Drug, Product Type & Application
2.7 Global Key Manufacturers of IL-4Rα Monoclonal Antibody Drug, Date of Enter into This Industry
2.8 Global IL-4Rα Monoclonal Antibody Drug Market Competitive Situation and Trends
2.8.1 Global IL-4Rα Monoclonal Antibody Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest IL-4Rα Monoclonal Antibody Drug Players Market Share by Revenue
2.8.3 Global IL-4Rα Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IL-4Rα Monoclonal Antibody Drug Market Scenario by Region
3.1 Global IL-4Rα Monoclonal Antibody Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global IL-4Rα Monoclonal Antibody Drug Sales by Region: 2019-2030
3.2.1 Global IL-4Rα Monoclonal Antibody Drug Sales by Region: 2019-2024
3.2.2 Global IL-4Rα Monoclonal Antibody Drug Sales by Region: 2025-2030
3.3 Global IL-4Rα Monoclonal Antibody Drug Revenue by Region: 2019-2030
3.3.1 Global IL-4Rα Monoclonal Antibody Drug Revenue by Region: 2019-2024
3.3.2 Global IL-4Rα Monoclonal Antibody Drug Revenue by Region: 2025-2030
3.4 North America IL-4Rα Monoclonal Antibody Drug Market Facts & Figures by Country
3.4.1 North America IL-4Rα Monoclonal Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America IL-4Rα Monoclonal Antibody Drug Sales by Country (2019-2030)
3.4.3 North America IL-4Rα Monoclonal Antibody Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe IL-4Rα Monoclonal Antibody Drug Market Facts & Figures by Country
3.5.1 Europe IL-4Rα Monoclonal Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe IL-4Rα Monoclonal Antibody Drug Sales by Country (2019-2030)
3.5.3 Europe IL-4Rα Monoclonal Antibody Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IL-4Rα Monoclonal Antibody Drug Market Facts & Figures by Region
3.6.1 Asia Pacific IL-4Rα Monoclonal Antibody Drug Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific IL-4Rα Monoclonal Antibody Drug Sales by Region (2019-2030)
3.6.3 Asia Pacific IL-4Rα Monoclonal Antibody Drug Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IL-4Rα Monoclonal Antibody Drug Market Facts & Figures by Country
3.7.1 Latin America IL-4Rα Monoclonal Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America IL-4Rα Monoclonal Antibody Drug Sales by Country (2019-2030)
3.7.3 Latin America IL-4Rα Monoclonal Antibody Drug Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa IL-4Rα Monoclonal Antibody Drug Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IL-4Rα Monoclonal Antibody Drug Sales by Type (2019-2030)
4.1.1 Global IL-4Rα Monoclonal Antibody Drug Sales by Type (2019-2024)
4.1.2 Global IL-4Rα Monoclonal Antibody Drug Sales by Type (2025-2030)
4.1.3 Global IL-4Rα Monoclonal Antibody Drug Sales Market Share by Type (2019-2030)
4.2 Global IL-4Rα Monoclonal Antibody Drug Revenue by Type (2019-2030)
4.2.1 Global IL-4Rα Monoclonal Antibody Drug Revenue by Type (2019-2024)
4.2.2 Global IL-4Rα Monoclonal Antibody Drug Revenue by Type (2025-2030)
4.2.3 Global IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Type (2019-2030)
4.3 Global IL-4Rα Monoclonal Antibody Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global IL-4Rα Monoclonal Antibody Drug Sales by Application (2019-2030)
5.1.1 Global IL-4Rα Monoclonal Antibody Drug Sales by Application (2019-2024)
5.1.2 Global IL-4Rα Monoclonal Antibody Drug Sales by Application (2025-2030)
5.1.3 Global IL-4Rα Monoclonal Antibody Drug Sales Market Share by Application (2019-2030)
5.2 Global IL-4Rα Monoclonal Antibody Drug Revenue by Application (2019-2030)
5.2.1 Global IL-4Rα Monoclonal Antibody Drug Revenue by Application (2019-2024)
5.2.2 Global IL-4Rα Monoclonal Antibody Drug Revenue by Application (2025-2030)
5.2.3 Global IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Application (2019-2030)
5.3 Global IL-4Rα Monoclonal Antibody Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Regeneron
6.1.1 Regeneron Company Information
6.1.2 Regeneron Description and Business Overview
6.1.3 Regeneron IL-4Rα Monoclonal Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Regeneron IL-4Rα Monoclonal Antibody Drug Product Portfolio
6.1.5 Regeneron Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi IL-4Rα Monoclonal Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi IL-4Rα Monoclonal Antibody Drug Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IL-4Rα Monoclonal Antibody Drug Industry Chain Analysis
7.2 IL-4Rα Monoclonal Antibody Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IL-4Rα Monoclonal Antibody Drug Production Mode & Process
7.4 IL-4Rα Monoclonal Antibody Drug Sales and Marketing
7.4.1 IL-4Rα Monoclonal Antibody Drug Sales Channels
7.4.2 IL-4Rα Monoclonal Antibody Drug Distributors
7.5 IL-4Rα Monoclonal Antibody Drug Customers
8 IL-4Rα Monoclonal Antibody Drug Market Dynamics
8.1 IL-4Rα Monoclonal Antibody Drug Industry Trends
8.2 IL-4Rα Monoclonal Antibody Drug Market Drivers
8.3 IL-4Rα Monoclonal Antibody Drug Market Challenges
8.4 IL-4Rα Monoclonal Antibody Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global IL-4Rα Monoclonal Antibody Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global IL-4Rα Monoclonal Antibody Drug Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global IL-4Rα Monoclonal Antibody Drug Market Competitive Situation by Manufacturers in 2023
 Table 4. Global IL-4Rα Monoclonal Antibody Drug Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global IL-4Rα Monoclonal Antibody Drug Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global IL-4Rα Monoclonal Antibody Drug Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market IL-4Rα Monoclonal Antibody Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of IL-4Rα Monoclonal Antibody Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of IL-4Rα Monoclonal Antibody Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of IL-4Rα Monoclonal Antibody Drug, Product Type & Application
 Table 12. Global Key Manufacturers of IL-4Rα Monoclonal Antibody Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IL-4Rα Monoclonal Antibody Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IL-4Rα Monoclonal Antibody Drug as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IL-4Rα Monoclonal Antibody Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global IL-4Rα Monoclonal Antibody Drug Sales by Region (2019-2024) & (K Units)
 Table 18. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share by Region (2019-2024)
 Table 19. Global IL-4Rα Monoclonal Antibody Drug Sales by Region (2025-2030) & (K Units)
 Table 20. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share by Region (2025-2030)
 Table 21. Global IL-4Rα Monoclonal Antibody Drug Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Region (2019-2024)
 Table 23. Global IL-4Rα Monoclonal Antibody Drug Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Region (2025-2030)
 Table 25. North America IL-4Rα Monoclonal Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America IL-4Rα Monoclonal Antibody Drug Sales by Country (2019-2024) & (K Units)
 Table 27. North America IL-4Rα Monoclonal Antibody Drug Sales by Country (2025-2030) & (K Units)
 Table 28. North America IL-4Rα Monoclonal Antibody Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America IL-4Rα Monoclonal Antibody Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe IL-4Rα Monoclonal Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe IL-4Rα Monoclonal Antibody Drug Sales by Country (2019-2024) & (K Units)
 Table 32. Europe IL-4Rα Monoclonal Antibody Drug Sales by Country (2025-2030) & (K Units)
 Table 33. Europe IL-4Rα Monoclonal Antibody Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe IL-4Rα Monoclonal Antibody Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific IL-4Rα Monoclonal Antibody Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific IL-4Rα Monoclonal Antibody Drug Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific IL-4Rα Monoclonal Antibody Drug Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific IL-4Rα Monoclonal Antibody Drug Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific IL-4Rα Monoclonal Antibody Drug Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America IL-4Rα Monoclonal Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America IL-4Rα Monoclonal Antibody Drug Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America IL-4Rα Monoclonal Antibody Drug Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America IL-4Rα Monoclonal Antibody Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global IL-4Rα Monoclonal Antibody Drug Sales (K Units) by Type (2019-2024)
 Table 51. Global IL-4Rα Monoclonal Antibody Drug Sales (K Units) by Type (2025-2030)
 Table 52. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share by Type (2019-2024)
 Table 53. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share by Type (2025-2030)
 Table 54. Global IL-4Rα Monoclonal Antibody Drug Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global IL-4Rα Monoclonal Antibody Drug Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Type (2019-2024)
 Table 57. Global IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Type (2025-2030)
 Table 58. Global IL-4Rα Monoclonal Antibody Drug Price (US$/Unit) by Type (2019-2024)
 Table 59. Global IL-4Rα Monoclonal Antibody Drug Price (US$/Unit) by Type (2025-2030)
 Table 60. Global IL-4Rα Monoclonal Antibody Drug Sales (K Units) by Application (2019-2024)
 Table 61. Global IL-4Rα Monoclonal Antibody Drug Sales (K Units) by Application (2025-2030)
 Table 62. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share by Application (2019-2024)
 Table 63. Global IL-4Rα Monoclonal Antibody Drug Sales Market Share by Application (2025-2030)
 Table 64. Global IL-4Rα Monoclonal Antibody Drug Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global IL-4Rα Monoclonal Antibody Drug Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Application (2019-2024)
 Table 67. Global IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Application (2025-2030)
 Table 68. Global IL-4Rα Monoclonal Antibody Drug Price (US$/Unit) by Application (2019-2024)
 Table 69. Global IL-4Rα Monoclonal Antibody Drug Price (US$/Unit) by Application (2025-2030)
 Table 70. Regeneron Company Information
 Table 71. Regeneron Description and Business Overview
 Table 72. Regeneron IL-4Rα Monoclonal Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Regeneron IL-4Rα Monoclonal Antibody Drug Product
 Table 74. Regeneron Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi IL-4Rα Monoclonal Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Sanofi IL-4Rα Monoclonal Antibody Drug Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Key Raw Materials Lists
 Table 81. Raw Materials Key Suppliers Lists
 Table 82. IL-4Rα Monoclonal Antibody Drug Distributors List
 Table 83. IL-4Rα Monoclonal Antibody Drug Customers List
 Table 84. IL-4Rα Monoclonal Antibody Drug Market Trends
 Table 85. IL-4Rα Monoclonal Antibody Drug Market Drivers
 Table 86. IL-4Rα Monoclonal Antibody Drug Market Challenges
 Table 87. IL-4Rα Monoclonal Antibody Drug Market Restraints
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IL-4Rα Monoclonal Antibody Drug
 Figure 2. Global IL-4Rα Monoclonal Antibody Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global IL-4Rα Monoclonal Antibody Drug Market Share by Type: 2023 & 2030
 Figure 4. 200mg (1.14mL)/Vial Product Picture
 Figure 5. 300mg (2.0 mL)/Vial Product Picture
 Figure 6. Global IL-4Rα Monoclonal Antibody Drug Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global IL-4Rα Monoclonal Antibody Drug Market Share by Application: 2023 & 2030
 Figure 8. Atopic Dermatitis
 Figure 9. Asthma
 Figure 10. Chronic Sinusitis with Nasal Polyps
 Figure 11. Other
 Figure 12. Global IL-4Rα Monoclonal Antibody Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global IL-4Rα Monoclonal Antibody Drug Market Size (2019-2030) & (US$ Million)
 Figure 14. Global IL-4Rα Monoclonal Antibody Drug Sales (2019-2030) & (K Units)
 Figure 15. Global IL-4Rα Monoclonal Antibody Drug Average Price (US$/Unit) & (2019-2030)
 Figure 16. IL-4Rα Monoclonal Antibody Drug Report Years Considered
 Figure 17. IL-4Rα Monoclonal Antibody Drug Sales Share by Manufacturers in 2023
 Figure 18. Global IL-4Rα Monoclonal Antibody Drug Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest IL-4Rα Monoclonal Antibody Drug Players: Market Share by Revenue in IL-4Rα Monoclonal Antibody Drug in 2023
 Figure 20. IL-4Rα Monoclonal Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global IL-4Rα Monoclonal Antibody Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America IL-4Rα Monoclonal Antibody Drug Sales Market Share by Country (2019-2030)
 Figure 23. North America IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Country (2019-2030)
 Figure 24. United States IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe IL-4Rα Monoclonal Antibody Drug Sales Market Share by Country (2019-2030)
 Figure 27. Europe IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Country (2019-2030)
 Figure 28. Germany IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific IL-4Rα Monoclonal Antibody Drug Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Region (2019-2030)
 Figure 35. China IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America IL-4Rα Monoclonal Antibody Drug Sales Market Share by Country (2019-2030)
 Figure 43. Mexico IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa IL-4Rα Monoclonal Antibody Drug Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE IL-4Rα Monoclonal Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of IL-4Rα Monoclonal Antibody Drug by Type (2019-2030)
 Figure 53. Global Revenue Market Share of IL-4Rα Monoclonal Antibody Drug by Type (2019-2030)
 Figure 54. Global IL-4Rα Monoclonal Antibody Drug Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of IL-4Rα Monoclonal Antibody Drug by Application (2019-2030)
 Figure 56. Global Revenue Market Share of IL-4Rα Monoclonal Antibody Drug by Application (2019-2030)
 Figure 57. Global IL-4Rα Monoclonal Antibody Drug Price (US$/Unit) by Application (2019-2030)
 Figure 58. IL-4Rα Monoclonal Antibody Drug Value Chain
 Figure 59. IL-4Rα Monoclonal Antibody Drug Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String